Labradimil
Labradimil is a selective bradykinin B2 receptor agonist that transiently increases blood-brain barrier permeability. It is used in research to enhance the delivery of hydrophilic chemotherapeutic agents like carboplatin to brain tumors, as demonstrated in both in vitro endothelial models and in vivo rodent studies of brain metastases.
Product Specifications
Field of Research
Pharmacology & Drug Discovery
Molecular Weight
1098.29
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS2106310 Inquire
PE-Linked Monoclonal Antibody to Tumor Necrosis Factor Alpha (TNFa)
Sign In for Pricing
View Details